$205.75
0.12%
NYSE, Jan 02, 10:04 pm CET
ISIN
US14149Y1082
Symbol
CAH

Cardinal Health Stock price

$205.72
+0.59 0.29% 1M
+43.74 27.00% 6M
+0.22 0.11% YTD
+87.70 74.31% 1Y
+128.85 167.62% 3Y
+152.79 288.66% 5Y
+117.77 133.91% 10Y
+156.35 316.73% 20Y
NYSE, Closing price Fri, Jan 02 2026
+0.22 0.11%

New AI Insights on Cardinal Health Insights AI Insights on Cardinal Health

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?
How is the company managed?

Key metrics

Basic
Market capitalization
$48.9b
Enterprise Value
$53.3b
Net debt
$4.4b
Cash
$4.6b
Shares outstanding
238.0m
Valuation (TTM | estimate)
P/E
30.8 | 20.7
P/S
0.2 | 0.2
EV/Sales
0.2 | 0.2
EV/FCF
12.0
P/B
negative
Dividends
DPS
$2.02
Yield 1Y | 5Y
1.0% | 2.3%
Growth 1Y | 5Y
34.7% | 1.0%
Payout 1Y | 3Y
31.4% | 50.6%
Increased
1 Year
Financials (TTM | estimate)
Revenue
$234.3b | $259.5b
EBITDA
$3.0b | $4.0b
EBIT
$2.7b | $3.4b
Net Income
$1.6b | $2.4b
Free Cash Flow
$4.5b
Growth (TTM | estimate)
Revenue
4.4% | 16.6%
EBITDA
22.3% | 42.0%
EBIT
22.6% | 37.1%
Net Income
26.3% | 51.3%
Free Cash Flow
313.0%
Margin (TTM | estimate)
Gross
3.7%
EBITDA
1.3% | 1.5%
EBIT
1.2%
Net
0.7% | 0.9%
Free Cash Flow
1.9%
Financial Health
Equity Ratio
-5.2%
Return on Equity
-56.1%
ROCE
18.0%
ROIC
-
Debt/Equity
-3.1
More
EPS
$6.7
FCF per Share
$18.7
Short interest
2.4%
Employees
48k
Rev per Employee
$4.6m
Show more

Is Cardinal Health a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,082 stocks worldwide.

Cardinal Health Stock Analysis

Unlock Scores for Free

Analyst Opinions

21 Analysts have issued a Cardinal Health forecast:

17x Buy
81%
4x Hold
19%

Analyst Opinions

21 Analysts have issued a Cardinal Health forecast:

Buy
81%
Hold
19%

Financial data from Cardinal Health

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
234,310 234,310
4% 4%
100%
- Direct Costs 225,725 225,725
4% 4%
96%
8,585 8,585
14% 14%
4%
- Selling and Administrative Expenses 5,566 5,566
10% 10%
2%
- Research and Development Expense - -
-
-
3,019 3,019
22% 22%
1%
- Depreciation and Amortization 322 322
20% 20%
0%
EBIT (Operating Income) EBIT 2,697 2,697
23% 23%
1%
Net Profit 1,595 1,595
26% 26%
1%

In millions USD.

Don't miss a Thing! We will send you all news about Cardinal Health directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Cardinal Health Stock News

Positive
Barrons
one day ago
With a 58% gain, CVS Health had its best year since 1982—and it wasn't the only strong performer.
Positive
Seeking Alpha
3 days ago
The ProShares S&P 500 Dividend Aristocrat ETF (NOBL) underperformed SPY in 2025, gaining 7.2% versus SPY's 18.42%. Despite average underperformance, select Aristocrats like CAH (+74.18%), ALB (+66.90%), and CHRW (+61.22%) delivered strong double-digit returns. Dividend growth for the Aristocrats slowed to 5.52% in 2025, down from 5.78% in 2024, with 68 of 69 raising payouts.
Positive
Seeking Alpha
20 days ago
In October, we (my wife and I) received a dividend income total of $3,948.78. Crushing it for an off-month – thanks to Vanguard (VOO) and Fidelity (FXAIX) for paying in October. We had quite a few dividend increases this month. So fortunate to be getting raises from companies and having the stocks of companies I own do all of the work. In total, dividend increases created $92.48 in additional p...
More Cardinal Health News

Company Profile

Cardinal Health, Inc. is a healthcare services and products company, which engages in the provision of customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices. It also provides medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency. The company operates through the following segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical and over-the-counter healthcare and consumer products. The Medical segment manufactures, sources and distributes cardinal health branded medical, surgical and laboratory products. The company was founded by Robert D. Walter in 1979 and is headquartered in Dublin, OH.

Head office United States
CEO Jason Hollar
Employees 48,411
Founded 1979
Website www.cardinalhealth.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today